<DOC>
	<DOCNO>NCT02930681</DOCNO>
	<brief_summary>Glucosanol previously proven effective aid weight loss weight loss maintenance . Studies also show Glucosanol ( also know Phaseolamin ) , effective aid weight loss also evidence reduce post-prandial glucose level . This study enrich exist evidence dose-dependent post-prandial glucose effect Glucosanol</brief_summary>
	<brief_title>Efficacy Glucosanol™ Reducing Post-prandial Glucose Levels Overweight Subjects</brief_title>
	<detailed_description />
	<mesh_term>Overweight</mesh_term>
	<mesh_term>Hyperglycemia</mesh_term>
	<criteria>Caucasian male female , 18 65 year old Body mass index ( BMI ) 25.029.9 kg/m2 Generally good health Normal fast blood glucose ( FBG ) 3.9 &lt; 5.6 mmol/L ( 70 &lt; 100 mg/dL ) glycated hemoglobin HbA1c 4 &lt; 5.7 % Readiness adhere consumption test meal define restriction prior test meal ( refer section 11.8 detail ) Readiness adhere habitual lifestyle study , particular : 1. maintain level physical activity study , include nonstrenuous transportation study visit 2. smoking , regular smoking level prior study smoking day test meal prior visit Stable body weight last 3 month prior V1 ( ≤5 % selfreported change ) Stable concomitant medication ( ) least last 3 month prior V1 Women childbearing potential : 1. negative pregnancy test ( ßHCG urine V1 ) 2. commitment use reliable contraception method Known sensitivity ingredient / excipients IP Known food allergy ( e.g . cow 's milk , egg , wheat , crustacean , nuts etc . ) Clinically relevant excursion safety parameter Digestion/absorption disorder gastrointestinal ( GI ) tract ( e.g . inflammatory bowel disease ) Uncontrolled hypertension &gt; 140/90 mmHg V1 Uncontrolled thyroid disorder V1 Any serious condition disease render subject ineligible Change daily dose treatment and/or use supplement possible impact glycemic control last 3 month prior V1 throughout study ( refer section 10 detail ) Use antidiabetic treatment use treatment and/or supplementation , reduction blood glucose level within last 4 week V1 throughout study Use medication dietary supplement may influence body weight ≤4 week gastrointestinal function ≤2 week prior V1 study Antibiotic cortisone therapy ≤2 week prior V1 study Vegetarians subject selfreported diet high fat protein Strenuous exercise within one day prior blood glucose sampling ( include V1 ) History bariatric surgery , small bowel resection extensive bowel resection Recent blood donation within ≤1 month prior study Alcohol abuse ( men : ≥21 units/week , woman : ≥14 units/ week ; 1 unit equal approximately 250 mL beer , 100 mL wine 35 mL spirit ) alcohol consumption within 24 h blood glucose sample Inability comply study procedure Pregnancy nurse Participation another study last 30 day screen visit ( V1 ) Any reason deem suitable exclusion , per investigator 's judgment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>